Search
for
Sort by
Research 901–930 of 1000+
- Pregnancy and Skin
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Dermatologic Problems of Older Women
- Efficacy and safety of microneedling and oral tranexamic acid in the treatment of facial melasma in women: An open, evaluator-blinded, randomized clinical trial
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Alopecia as a systemic disease
- Pruritic urticarial papules and plaques of pregnancy
- Isomorphic and isotopic phenomenon occurring simultaneously in a case of granuloma annulare
- Social isolation: main dermatosis and the impact of stress during the COVID-19 pandemic
- Dermatology Issues in Sports
- Effects of Wet Cupping on Blood Components Specially Skin-Related Parameters of Healthy Cases: A Case Control Metabonomic Study
- [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Cutaneous Manifestations of COVID-19
- Hair and Scalp Infections
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Autologous Mini Punch Graft in Vitiligo: A Narrative Review
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- A clinical study of Geriatric dermatoses at Tertiary care center in South India
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- The Effect of the COVID-19 Pandemic on Stress-related Dermatologic Diseases.
- Change in dermatology practice during crisis and normalization periods after the COVID-19 pandemic and potential problems awaiting us
- Erosive Pustular Dermatosis of the Scalp
- Impact of Coronavirus in a Dermatology Outpatient Clinic: A Single-Center Retrospective Study